Caroline Pallard

Caroline Pallard

Partner since 2012

Dutch and European patent attorney

  • Immunoglobulin
  • Biotechnology
  • Pharmacy
  • Gene therapy
  • Oligonucleotide
  • Opposition
  • Plants
Dutch, English and French

Caroline joined NLO in 2006. Previously, she worked as a European and Dutch patent attorney in the patent department of DSM/Gist- brocades in Delft. Prior to that, she was a postdoctoral fellow at the Dutch Cancer Institute (Nederlands Kanker Instituut) (1996-1998) where she focused on immunology and biochemistry.



Caroline specialises in biotechnology, particularly molecular biology, genomics, biochemistry, haematology especially immunology and microbiology. She has extensive experience in drafting and prosecuting complex patent applications. Caroline frequently advises biotech startups on their IP strategies. She also has experience in supporting complex licence negotiations in which IP is pivotal and in advising clients before and during IPO processes (Initial Public Offer).



Caroline has a PhD in biochemistry and haematology from the Institut Cochin de Génétique Moléculaire in Paris (1993-1996). Prior to that, after a national competition, she was admitted into a “Grande école” in Paris, at which she studied for three years (1990-1993). This “Grande école” (Institut National Agronomique Paris Grignon, INAPG) specialises in biotechnology and biochemistry. Caroline obtained the title European and Dutch patent attorney at DSM/Gist- brocades in Delft (1998-2004).


More information

Caroline often publishes articles on European case law in prestigious magazines such as IAM and MIP. Her native language is French. She is fluent in Dutch.



Working at NLO

On a regular basis we are looking for people to join our company. Are you interested in a career at NLO? Please visit our special working at NLO website.

Intellectual Property: Cases

Intellectual Property is a valuable asset. From start-up to market leader, applying a smart strategy for patents, trademarks and/or designs adds value to every company. Examples of such successful IP strategies can be found at our page ‘Cases’. Read more